Patients' and researchers' experiences with a patient board for a clinical trial on urinary tract infections

被引:14
作者
Schilling I. [1 ,2 ]
Behrens H. [1 ]
Bleidorn J. [3 ,4 ]
Gágyor I. [5 ,6 ]
Hugenschmidt C. [1 ]
Jilani H. [1 ,2 ]
Schmiemann G. [1 ,2 ,4 ]
Gerhardus A. [1 ,2 ]
机构
[1] Department for Health Services Research, Institute of Public Health and Nursing Research, University of Bremen, Grazer Straße 4, Bremen
[2] Health Sciences Bremen, University of Bremen, Bremen
[3] Institute of General Practice, Jena University Hospital, Bachstr. 18, Jena
[4] Institute of General Practice, Medical School Hannover, Carl-Neuberg-Str. 1, Hannover
[5] Institute of General Practice, Würzburg University Hospital, Joseph-Schneider-Str.2/D7, Würzburg
[6] Institute of General Practice, Göttingen University Hospital, Humboldtallee 38, Göttingen
关键词
Challenges; Clinical trial; Experiences; Patient and public involvement; Patient board; Patient engagement; PPI; Qualitative research;
D O I
10.1186/s40900-019-0172-0
中图分类号
学科分类号
摘要
Background: Patient and public involvement (PPI) has become an essential part of the design, conduct, and dissemination of research. While researchers who employed PPI mainly report on the positive aspects, in practice PPI is still an exception in clinical trials in Germany. There are specific challenges in the process of involvement that can jeopardize the conduct of involvement. The aim of our study was to analyze the experience of patients and researchers with PPI in a clinical trial in Germany, so we could learn more about potential challenges and how they could be addressed. Methods: We established a patient board for a randomized controlled trial on urinary tract infections, where patients and researchers regularly met to discuss relevant aspects of the trial. Minutes were taken for each meeting and the moderator also noted her observations in a postscript. After four meetings, we conducted two focus groups, one each with the patients and researchers. We analyzed and categorized the minutes, postscripts, and focus group transcripts using thematic qualitative text analysis. Results: Patients and researchers felt comfortable with the composition of the patient board and its' atmosphere. In terms of challenges, patients and researchers needed time to get familiar with PPI. Both parties saw a need for training in PPI but differed in their views on the relevant topics. Patients wished to learn more about their role and tasks within the board at the onset of the PPI. They also preferred to meet more frequently and get more intensely involved in the trial. In contrast, researchers perceived that they were already highly involved. They further felt that the involvement was of benefit to them, the trial and future research. Patients described benefits for themselves, but also wondered if their involvement had had an impact on the trial. Conclusions: To facilitate effective PPI, resources, adequate structures, and training are needed. Patients and researchers need to agree on their respective roles, training needs, and the mode of cooperation right at the beginning. The parties involved should continuously reflect on the actual benefits of PPI, describe them explicitly and make them transparent for all. © 2019 The Author(s).
引用
收藏
相关论文
共 50 条
[31]   A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction [J].
Welk, Blayne ;
Hickling, Duane ;
McKibbon, Mary ;
Radomski, Sidney ;
Ethans, Karen .
NEUROUROLOGY AND URODYNAMICS, 2018, 37 (08) :2810-2817
[32]   Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections [J].
Thibon, P ;
Le Coutour, X ;
Leroyer, R ;
Fabry, J .
JOURNAL OF HOSPITAL INFECTION, 2000, 45 (02) :117-124
[33]   Exploring Australian regional cancer patients' experiences of clinical trial participation via telemedicine technology [J].
Lee, Jin Joo ;
Burbury, Kate ;
Underhill, Craig ;
Harris, Samuel ;
Shackleton, Kylie ;
McBurnie, Jacquiline ;
McPhee, Narelle ;
Osmond, Felicity ;
Wilkins, Kathleen ;
Baden, Paul ;
Krishnasamy, Meinir .
JOURNAL OF TELEMEDICINE AND TELECARE, 2022, 28 (07) :508-516
[34]   Terazosin therapy for patients with female lower urinary tract symptoms: A randomized, double-blind, placebo controlled trial [J].
Low, Bee Yean ;
Liong, Men Long ;
Yuen, Kah Hay ;
Chee, Christopher ;
Leong, Wing Seng ;
Chong, Wooi Loong ;
Khan, Nurzalina Abdul Karim ;
Cheah, Phaik Yeong ;
Liong, Ker Keong .
JOURNAL OF UROLOGY, 2008, 179 (04) :1461-1469
[35]   A phase I clinical trial assessing the safety, tolerability, and pharmacokinetics of inhaled ethanol in humans as a potential treatment for respiratory tract infections [J].
Hancock, David G. ;
Ditcham, William ;
Ferguson, Eleanor ;
Karpievitch, Yuliya V. ;
Stick, Stephen M. ;
Waterer, Grant W. ;
Clements, Barry S. .
FRONTIERS IN MEDICINE, 2024, 11
[36]   Homeopathic medicines for prevention of influenza and acute respiratory tract infections in children: blind, randomized, placebo-controlled clinical trial [J].
Siqueira, Camila Monteiro ;
Homsani, Fortune ;
da Veiga, Venicio Feo ;
Lyrio, Carlos ;
Mattos, Haroldo ;
Lambert Passos, Sonia Regina ;
Couceiro, Jose Nelson ;
Quaresma, Carla Holandino .
HOMEOPATHY, 2016, 105 (01) :71-77
[37]   An open label, non-controlled, multicentre, interventional trial to investigate the safety and efficacy of Canephron® N in the management of uncomplicated urinary tract infections (uUTIs) [J].
Dmitry Ivanov ;
Dimitri Abramov-Sommariva ;
Kathrin Moritz ;
Herbert Eskötter ;
Tatyana Kostinenko ;
Liliya Martynyuk ;
Nikolay Kolesnik ;
Kurt G Naber .
Clinical Phytoscience, 1 (1)
[38]   Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK2140944) [J].
Andrea Nuzzo ;
Stephanie Van Horn ;
Christopher Traini ;
Caroline R. Perry ;
Etienne F. Dumont ;
Nicole E. Scangarella-Oman ;
David F. Gardiner ;
James R. Brown .
BMC Microbiology, 21
[39]   Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK140944) [J].
Nuzzo, Andrea ;
Van Horn, Stephanie ;
Traini, Christopher ;
Perry, Caroline R. ;
Dumont, Etienne F. ;
Scangarella-Oman, Nicole E. ;
Gardiner, David F. ;
Brown, James R. .
BMC MICROBIOLOGY, 2021, 21 (01)
[40]   Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan [J].
Alexandra Wharton-Smith ;
Shona Horter ;
Emma Douch ;
Nell Gray ;
Nicola James ;
Bern-Thomas Nyang’wa ;
Jatinder Singh ;
Parpieva Nargiza Nusratovna ;
Zinaida Tigay ;
Emil Kazounis ;
Gulayim Allanazarova ;
Beverley Stringer .
Trials, 22